DS-1001B OPTIONS

DS-1001b Options

quinupristin/dalfopristin will raise the amount or impact of alfentanil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.quinupristin/dalfopristin will improve the amount or effect of lumateperone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Minimize lumateperone do

read more